Gene · 5422
Papers4,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Refining Timely Diagnosis of Early Syphilis by Using Treponema pallidum PCR or IgM Immunoblotting Next to Conventional Serology for Syphilis. | J Clin Microbiol | 2023 | 37222630 | PubTator, text mining | PubMed |
| Red Blood Cell Lysis Pretreatment Can Significantly Improve the Yield of Treponema pallidum DNA from Blood. | Microbiol Spectr | 2023 | 37222624 | PubTator, text mining | PubMed |
| Functional biology and biotechnology of thermophilic viruses. | Essays Biochem | 2023 | 37222046 | PubTator, text mining | PubMed |
| Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication. | Mol Cancer Ther | 2023 | 37216280 | PubTator, text mining | PubMed |
| GSK-3484862 targets DNMT1 for degradation in cells. | NAR Cancer | 2023 | 37206360 | PubTator, text mining | PubMed |
| PCNA Ser46-Leu47 residues are crucial in preserving genomic integrity. | PLoS One | 2023 | 37205694 | PubTator, text mining | PubMed |
| Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer (POLA)-Study protocol for a single-arm prospective observational multicenter study. | PLoS One | 2023 | 37205666 | PubTator, text mining | PubMed |
| Multiomics analysis of adaptation to repeated DNA damage in prostate cancer cells. | Epigenetics | 2023 | 37196186 | PubTator, text mining | PubMed |
| Noncanonical Roles of RAD51. | Cells | 2023 | 37190078 | PubTator, text mining | PubMed |
| A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma. | Front Oncol | 2023 | 37188190 | PubTator, text mining | PubMed |
| Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner. | Front Pharmacol | 2023 | 37180705 | PubTator, text mining | PubMed |
| Association of Mutations in Replicative DNA Polymerase Genes with Human Disease: Possible Application of Drosophila Models for Studies. | Int J Mol Sci | 2023 | 37175782 | PubTator, text mining | PubMed |
| The Activity of Natural Polymorphic Variants of Human DNA Polymerase β Having an Amino Acid Substitution in the Transferase Domain. | Cells | 2023 | 37174699 | PubTator, text mining | PubMed |
| An evaluation of a multiplex PCR assay for the detection of Treponema pallidum, HSV-1, and HSV-2. | Diagn Microbiol Infect Dis | 2023 | 37172529 | PubTator, text mining | PubMed |
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma. | Ann Hematol | 2023 | 37171597 | PubTator, text mining | PubMed |
| Type I Interferonopathies in Childhood. | Balkan Med J | 2023 | 37161741 | PubTator, text mining | PubMed |
| Bacillus subtilis encodes a discrete flap endonuclease that cleaves RNA-DNA hybrids. | PLoS Genet | 2023 | 37146086 | PubTator, text mining | PubMed |
| Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe. | Nucleic Acids Res | 2023 | 37144518 | PubTator, text mining | PubMed |
| Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy. | J Med Chem | 2023 | 37134182 | PubTator, text mining | PubMed |
| DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer. | Exp Mol Med | 2023 | 37121974 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5422/papers?page=12